Advanced Technology

The MV Hondius hantavirus outbreak exposed a critical surveillance gap: by the time official alerts were issued, exposed passengers had already dispersed across multiple countries. This article explores how infection preventionists can use emerging open-source dashboards, real-time data aggregation tools, and internal informatics systems to bridge the dangerous lag between exposure events and actionable public health intelligence. From cruise ship outbreaks to facility-level exposures, the piece examines how digital surveillance may help IPs shift from reactive outbreak reconstruction to faster, proactive containment strategies.

The global infection control supplies market is projected to grow from $58.5 billion in 2026 to $106.1 billion by 2035 as healthcare systems invest more heavily in infection prevention, sterilization technologies, PPE, and automated disinfection solutions. Driven by rising healthcare-associated infections, aging populations, chronic disease burden, and increasing regulatory pressure, the market is evolving toward smarter, technology-enabled infection prevention strategies across hospitals, ambulatory surgical centers, and outpatient care settings.

New evidence suggests UV-C disinfection may do more than reduce pathogens. Repeated exposure can also damage common health care plastics, potentially creating microcracks and roughened surfaces that harbor microorganisms. Experts say material compatibility must become part of every UV-C infection prevention strategy.

As people with HIV live longer due to ART, new challenges are emerging. Aging with HIV is linked to higher risks of comorbidities, chronic inflammation, and drug interactions, while gaps in clinical trial inclusion and care models highlight the need for more integrated, patient-centered treatment strategies.

AI and agentic systems are transforming infection prevention by enabling real-time surveillance, predictive risk modeling, and earlier intervention, shifting health care from reactive response to proactive prevention and improving patient safety outcomes.

New research shows the Marburg virus enters human cells far more efficiently than Ebola, highlighting increased outbreak risk and underscoring the need for rapid detection, strict infection control, and novel antiviral development.

Peptilogics' PLG0206 represents a breakthrough innovation in infectious disease. First drug designed specifically to penetrate and kill biofilm-protected bacteria. RETAIN Phase 2/3 trial now enrolling patients with prosthetic joint infection. The previous phase showed 93% infection-free rate. It could revolutionize the treatment of medical device-related infections.

A multicenter randomized trial of 276 patients with sepsis found that precision immunotherapy targeting immune dysfunction improved organ failure scores by day 9 compared with placebo. Although mortality differences were not statistically significant, the results suggest that biomarker-guided treatment strategies could help personalize sepsis care and improve clinical outcomes.

Cepheid has been selected by the CDC as a national collaborator to accelerate rapid diagnostic development during public health emergencies. With early access to outbreak samples and genomic data, the company aims to shorten response timelines and strengthen U.S. pandemic preparedness through scalable, high accuracy PCR testing solutions.

Could engineered bacteriophages help hospitals tackle drug-resistant infections when antibiotics fail? In this ICT Q&A, researchers discuss where phage engineering may realistically fit first in hospitals, from treatment of MDR infections to environmental control, and why broad-coverage phage products remain a longer-term goal.

As 2026 begins, Infection Control Today®'s Editorial Advisory Board reflects on a challenging year shaped by misinformation, policy uncertainty, and relentless change, reaffirming a commitment to science, truth, and supporting IPC professionals who keep showing up for patients and public health.

Missed opportunities, Graves warned, place patients at risk. Many surgical patients are immunocompromised, and a stethoscope may come near the incision. “Regardless of the scenario, [cleaning the stethoscope] each time is going to protect patients.”

The November/December 2025 issue of Infection Control Today® dives into overlooked risks, breakthrough technologies, and the people driving innovation across IPC, EVS, and sterile processing. From bacteriophage therapy to burnout prevention, automation to UV regulation—it’s a powerful close to the year. Read the issue now: https://www.infectioncontroltoday.com/journals/infection-control-today #InfectionPrevention #Healthcare #InfectionControl #EVS #IPC #PatientSafety #ICT

Sterile technique, specialized training, patient safety—Certified Surgical Technologists do it all. Learn how their role is evolving in today’s high-tech operating room.

Measuring cleaning is not the same as proving disinfection. Infection preventionists must use ATP and fluorescent markers wisely—supporting training, not replacing microbial validation.

Artificial intelligence may be revolutionizing sepsis detection and diagnosis, but can we trust it without strong regulatory guardrails? As AI/ML-enabled medical devices rapidly evolve, IPs must stay informed and involved to ensure safety keeps pace with innovation. Let’s take a closer look at how to advocate for innovative safe implementation.

Sterilization is the backbone of safe patient care, but not all methods are created equal. From steam’s tried-and-true reliability to ethylene oxide’s versatility for complex devices and hydrogen peroxide plasma’s rapid, residue-free cycles, each technique carries unique advantages—and limitations. Understanding when and how to use them can mean the difference between seamless infection prevention and costly setbacks.

Join global leaders in infection prevention, pandemic response, and public health strategy at the Health Watch USA 20th Annual Conference. This is your chance to gain actionable insights on emerging pathogens, vaccine misinformation, and antibiotic resistance, while earning CE credits at no cost. Don’t wait; Be part of the solution.

At the 2025 HSPA Annual Conference & Expo, Cori L. Ofstead, MSPH, highlighted critical flaws in manufacturers’ instructions for use (IFUs) for orthopedic and neurosurgical instruments. From contradictory directions to unrealistic cleaning expectations, these IFUs often fail under real-world conditions, jeopardizing both patient safety and sterile processing workflows.

From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.

In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.

Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.

Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.

With surgical site infections on the rise, experts argue that systemic antibiotics fall short, and targeted drug delivery may be the future of surgical infection prevention.